Driver

Transcat expands biomedical business with $12.8M acquisition. Rochester-based Transcat Inc. is expanding its biomedical calibration business into the southeastern U.S. with the $12.8 million acquisition of a North Carolina company that serves hospitals and health care facilities. Transcat announced this week that it acquired privately held Southeastern Biomedical Associates Inc. The purchase price was paid in cash and is subject to customary adjustments and holdback provisions. Founded in 1996 and based in Granite Falls, North Carolina, Southeastern provides calibration, repair, preventive maintenance, electrical safety inspections, documentation and regulatory compliance services to hospital networks and other health care facilities throughout the Southeast and beyond. The company also sells biomedical equipment, patient-ready accessories and equipment parts. Its services include helping customers acquire equipment and liquidate assets. The acquisition builds on Transcat's existing biomedical business while expanding its geographic reach in a market the company expects to grow, according to company leaders. For Transcat, the deal is part of a broader strategy to build scale in highly regulated industries where equipment failures can carry significant financial, operational and safety consequences. "The acquisition of Southeastern Biomedical reinforces Transcat's strategy of deepening our presence in the Life Science sector, one of the most regulated and mission-critical end markets we serve," said Jaime Irick, Transcat's president and CEO. Transcat has more than 30 calibration laboratories across North and Central America. The company sees that footprint as a competitive advantage as hospital networks and other regulated customers increasingly need consistent, accredited calibration services across multiple locations. Irick said Southeastern's reputation and customer base will allow Transcat to serve a larger geography while maintaining its focus on quality and turnaround times. The acquisition also brings Southeastern's employees and owners into Transcat. Co-owners Boyd Campbell and Greg Johnson will join the company. Southeastern has built its business over more than three decades serving customers throughout the Southeast and beyond, Johnson said. He said Transcat was the right partner to support the company's next phase of growth. "Transcat has developed a reputation in this industry for treating acquired employees and customers right," Johnson said, adding that he and Campbell look forward to being part of the future of Transcat Biomedical. The acquisition comes as Transcat continues to emphasize mergers and acquisitions as part of its growth strategy. Irick said the combination should create opportunities to expand service across the companies' customer bases while maintaining what he described as industry-leading turnaround times.

Transcat acquires Southeastern Biomedical. The acquisition expands Transcat's biomedical service footprint across the Southeast, including calibration, repair, and preventive maintenance for healthcare facilities. Transcat has acquired Southeastern Biomedical Associates for $12.8 million in cash, effective Aug 31, 2026. The acquisition expands Transcat's accredited biomedical calibration, equipment repair, and preventive maintenance services throughout the southeastern United States. Based in Granite Falls, NC, Southeastern Biomedical Associates provides calibration, repair, electrical safety inspection, and regulatory compliance services to hospital networks and healthcare facilities. The company's services conform to both ISO/IEC 17025 and ISO 9001 standards. In addition to service, the company sells biomedical equipment, patient-ready accessories, and equipment parts. The acquisition is intended to build scale in regulated end markets where accredited calibration is critical to patient safety and regulatory compliance, according to a release from Transcat. Transcat operates more than 30 calibration labs across North and Central America. "The acquisition of Southeastern Biomedical reinforces Transcat's strategy of deepening our presence in the Life Science sector, one of the most regulated and mission-critical end markets we serve," says Jaime Irick, president and CEO, in a release. "Southeastern's reputation for high quality and a customer-first approach supporting hospital networks throughout the southeastern region of the United States and beyond builds on our established leadership in biomedical calibration and will position us to service a much larger geography with a consistent focus on quality and timely service for our customers in these critical end markets." Southeastern Biomedical Associates owners Boyd Campbell and Greg Johnson will remain with Transcat to lead the growth of the combined biomedical business. "There was never a doubt that Transcat was the right partner to take our company to the next level of growth," says Greg Johnson, co-owner of Southeastern Biomedical Associates, in a release. "Transcat has developed a reputation in this industry for treating acquired employees and customers right, and for focusing on the key attributes and operating principles that have made Southeastern successful over time." The purchase price is subject to certain customary adjustments and holdback provisions. According to Transcat, the acquisition supports the company's fiscal 2027 outlook, which includes continued mergers and acquisitions and service gross margin expansion.